Journal Article

Raynaud phenomenon: from GWAS to drug repurposing

Nature Reviews Rheumatology (2024) 20(3) 139-140
DOI: 10.1038/s41584-024-01076-x
0Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The identification of novel risk variants in the largest genome-wide association study of Raynaud phenomenon to date provides insights into the pathophysiology of the condition, including the potential role for α2A-adrenoceptors, and suggests opportunities for drug repurposing.

Cite

CITATION STYLE

APA

Herrick, A. L., & Orozco, G. (2024). Raynaud phenomenon: from GWAS to drug repurposing. Nature Reviews Rheumatology, 20(3), 139–140. https://doi.org/10.1038/s41584-024-01076-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free